Developments in Cannabinoid Medicines
5 February 2019
Cannabis has been used as a medicine for thousands of years. Internationally the laws governing the medical and non-medical use of cannabis and cannabinoids (the chemical constituents of cannabis) are rapidly evolving.
In this lecture Dr Bloomfield will explain what is a cannabinoid and will present current research into cannabinoid medicines together with data, including from his laboratory, on how cannabinoids act on the body.
CV: Dr Bloomfield is a UCL Excellence Fellow. He leads the Translational Psychiatry Research Group and is an Honorary Consultant Psychiatrist at the Traumatic Stress Clinic in London. He studied Natural Sciences specializing in neuroscience, pharmacology and psychology, at Corpus Christi College, Oxford. He then studied Clinical Medicine at Oxford. He began his clinical Psychiatry training on the Charing Cross rotation, where he worked at Charing Cross and Chelsea & Westminster Hospitals. He was then appointed a Medical Research Council Clinical Research Fellow at the Imperial College London Institute of Clinical Sciences in Hammersmith Hospital.
Michael’s research seeks to understand the mechanisms underlying how exposure to risk factors for mental illness during childhood and adolescence alter brain and cognitive function to give rise to mental illnesses so that new treatment and preventative interventions can be developed. He has been awarded young investigator prizes from major national and international research societies. He has published over 40 papers in peer-reviewed journals, including Nature, and has a co-authored book chapter for the Oxford Textbook of Psychosis currently in press.
Date and time: Wednesday 13th March 2019 from 5:00pm
Venue: UCL School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX
Tickets for this free event will be available from 25 February. Please make sure to register via the link below:
Contact: Professor Michael Heinrich